Press Releases

SAN FRANCISCO--(BUSINESS WIRE)-- Okta, Inc. (NASDAQ: OKTA), the leading independent identity partner, today announced that Brett Tighe, Chief Financial Officer of Okta, is scheduled to participate in the following upcoming investor conference.

Nasdaq Investor Conference in London, United Kingdom Presenter: Brett Tighe, Chief Financial Officer Tuesday, June 11, 2024 at 09:30 a.m. Greenwich Mean time (01:30 a.m. Pacific time)

The presentation will be webcast live... (continue reading...)

Clinical testing of LP-310 expected to commence in mid-2024

Patient recruitment is underway for Phase 2a multicenter, dose-ranging study

PITTSBURGH, May 31, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced the successful completion of its first Site Initiation Visit... (continue reading...)

WALTHAM, Mass.--(BUSINESS WIRE)-- Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that senior management will participate in the following upcoming investor conferences in June:

• Jefferies Global Healthcare Conference (New York, NY): Presentation on Wednesday, June 5, 2024, at 5:00 p.m. ET.

• Goldman Sachs 45th Annual... (continue reading...)

WASHINGTON, May 31, 2024 /PRNewswire/ -- The Eleanor Crook Foundation (ECF), the Bill & Melinda Gates Foundation, the Children's Investment Fund Foundation (CIFF), and Kirk Humanitarian have announced a groundbreaking investment roadmap to reach millions more pregnant women in low- and middle-income countries with a complete prenatal supplement, known as multiple micronutrient supplementation, or MMS.* 

"Healthier Pregnancies and Brighter Futures for Mothers and... (continue reading...)

MUNICH and ANN ARBOR, Mich., May 31, 2024 /PRNewswire/ -- WACKER has acquired the manufacturing assets and know-how of U.S.-based Bio Med Sciences Inc. to expand its expertise and business in silicone-coated healthcare products. A corresponding purchase agreement was signed yesterday between WACKER and the Pennsylvania-based company. As part of the acquisition, a majority of Bio Med Sciences' workforce will also move to WACKER. Both parties have agreed not to disclose... (continue reading...)